• Quotes

  • NAVs

  • News

  • Messages

  • Opinions

  • Notices

  • Videos

Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 16440.56 -58.16 NIFTY 4881.70 -16.70
 

Glenmark Pharma Cash Flow, Glenmark Pharma Financial Statement & Accounts
You are here : Moneycontrol » Markets » Cash Flow - Glenmark Pharma

Glenmark Pharma

BSE: 532296  |  NSE: GLENMARK  |  ISIN: INE935A01035  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Cash Flow of Glenmark Pharma

 ------------------- in Rs. Cr. -------------------
Mar '05 Mar '06 Mar '07 Mar '08 Mar '09
12 mths 12 mths 12 mths 12 mths 12 mths
Net Profit Before Tax 86.94 85.30 170.82 431.19 246.07
Net Cash From Operating Activities 10.11 -25.49 -8.83 246.67 94.06
Net Cash (used in)/from
Investing Activities		 -203.87 -239.08 -237.92 -15.70 -589.14
Net Cash (used in)/from Financing Activities 296.27 244.45 168.98 -231.18 495.62
Net (decrease)/increase In Cash and Cash Equivalents 102.51 -20.12 -77.77 -0.21 0.53
Opening Cash & Cash Equivalents 6.77 109.28 89.16 11.39 11.16
Closing Cash & Cash Equivalents 109.28 89.16 11.39 11.18 11.69
Source : Religare Technova
Explore Glenmark connections